NCI advisors table proposed $186.5 million nanotechnology research program. NCI proposed to fund three to five “centers for cancer nanotechnology excellence,” a coordinating center, and training programs. Board members said they needed more time, information, to make decision. NCI director asked board to “think big” about nanotechnology. Deputy director called nanotechnology program “transformational.”
Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.
DOD funds $4.2 million gynecologic oncology research program at four institutions.
June issue of Business & Regulatory Report included.
Trending Stories
- Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - John Burklow replaced by Seana Cranston as NIH chief of staff
- In the Headlines: What’s in Trump’s draft budget?
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - NCI summarizes changes to the CCSG NOFO
- City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows